Post menopausal hormones and measures of subclinical atherosclerosis: The multi-ethnic study of atherosclerosis

Preventive Medicine

Volumn 47, Issue 1, 2008, Pages 38-45

  Shahar, Eyal ^a   Burke, Gregory L ^b   Cushman, Mary ^c   Heckbert, Susan R ^d   Ouyang, Pamela ^e   Szklo, Moyses ^f  

^a UNIVERSITY OF ARIZONA   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Atherosclerosis; Carotid wall thickness; Coronary calcification; Post menopausal hormones

Indexed keywords

ESTROGEN; GESTAGEN;

ADULT; AGED; ARTERY CALCIFICATION; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG USE; ETHNIC DIFFERENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; POSTMENOPAUSE; PRIORITY JOURNAL; TREATMENT DURATION;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; CALCIUM; CAROTID ARTERIES; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY VESSELS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; SOCIOECONOMIC FACTORS; TUNICA INTIMA;

EID: 45449118916     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2007.12.013     Document Type: Article

References (53)

1. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. The writing group for the PEPI trial. JAMA 273 (1995) 199-208
2. Adams M.R., Kaplan J.R., Manuck S.B., et al. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone. Arteriosclerosis 10 (1990) 1051-1057
3. Agatston A.S., Janowitz W.R., Hildner F.J., Zusmer N.R., Viamonte Jr. M., and Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J. Am. Coll. Cardiol. 15 (1990) 827-832
4. Akhrass F., Evans A.T., Wang Y., et al. Hormone replacement therapy is associated with less coronary atherosclerosis in postmenopausal women. J. Clin. Endocrinol. Metab. 88 (2003) 5611-5614
5. Angerer P., Stork S., Kothny W., and von Schacky C. Effect of postmenopausal hormone replacement on atherosclerosis in femoral arteries. Maturitas 41 (2002) 51-60
6. Angerer P., Stork S., Kothny W., Schmitt P., and von Schacky C. Effect of oral postmenopausal hormone replacement on progression of atherosclerosis: a randomized, controlled trial. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 262-268
7. Barlow D.H. HRT and the risk of deep vein thrombosis. Int. J. Gynaecol. Obstet. 59 Suppl 1 (1997) S29-S33
8. Baron Y.M., Galea R., and Brincat M. Carotid artery wall changes in estrogen-treated and -untreated postmenopausal women. Obstet. Gynecol. 91 (1998) 982-986
9. Barrett-Connor E. Commentary: observation versus intervention-what's different?. Int. J. Epidemiol. 33 (2004) 457-459
10. Bild D.E., Bluemke D.A., Burke G.L., et al. Multi-ethnic study of atherosclerosis: objectives and design. Am. J. Epidemiol. 156 (2002) 871-881
11. Breen J.F., Sheedy P.F., Schwartz R.S., et al. Coronary artery calcification detected with ultrafast CT as an indication of coronary artery disease. Radiology 185 (1992) 435-439
12. Carr J.J., Nelson J.C., Wong N.D., et al. Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. Radiology 234 (2005) 35-43
13. Carr J.J., Crouse J.R., Goff Jr. D.C., D'Agostino Jr. R.B., Peterson N.P., and Burke G.L. Evaluation of subsecond gated helical CT for quantification of coronary artery calcium and comparison with electron beam CT. Am. J. Roentgenol. 174 (2000) 915-921
14. Cushman M., Legault C., Barrett-Connor E., et al. Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) study. Circulation 100 (1999) 717-722
15. Dubuisson J.T., Wagenknecht L.E., D'Agostino Jr. R.B., et al. Association of hormone replacement therapy and carotid wall thickness in women with and without diabetes. Diabetes Care 21 (1998) 1790-1796
16. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18 (1972) 499-502
17. Garbe E., and Suissa S. Hormone replacement therapy and acute coronary outcomes: methodological issues between randomized and observational studies. Hum. Reprod. 19 (2004) 8-13
18. Grady D., and Hulley S.B. Postmenopausal hormones and heart disease. J. Am. Coll. Cardiol. 38 (2001) 8-10
19. Griewing B., Romer T., Spitzer C., Ludemann J., Gunther A., and Kessler C. Hormone replacement therapy in postmenopausal women: carotid intima-media thickness and 3-D volumetric plaque quantification. Maturitas 32 (1999) 33-40
20. Harman S.M., Brinton E.A., Clarkson T., et al. Is the WHI relevant to HRT started in the perimenopause?. Endocrine 24 (2004) 195-202
21. Herrington D.M., Reboussin D.M., Brosnihan K.B., et al. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N. Engl. J. Med. 343 (2000) 522-529
22. Hodis H.N., Mack W.J., Lobo R.A., et al. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 135 (2001) 939-953
23. Hoibraaten E., Qvigstad E., Andersen T.O., Mowinckel M.C., and Sandset P.M. The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism-results from a randomized, double-blind, clinical trial. Thromb. Haemost. 85 (2001) 775-781
24. Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) research group. JAMA 280 (1998) 605-613
25. Jonas H.A., Kronmal R.A., Psaty B.M., et al. Current estrogen-progestin and estrogen replacement therapy in elderly women: association with carotid atherosclerosis. CHS collaborative research group. Cardiovascular Health Study. Ann. Epidemiol. 6 (1996) 314-323
26. Kuller L.H., Matthews K.A., Sutton-Tyrrell K., Edmundowicz D., and Bunker C.H. Coronary and aortic calcification among women 8 years after menopause and their premenopausal risk factors: the healthy women study. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 2189-2198
27. Le Gal G., Gourlet V., Hogrel P., Plu-Bureau G., Touboul P.J., and Scarabin P.Y. Hormone replacement therapy use is associated with a lower occurrence of carotid atherosclerotic plaques but not with intima-media thickness progression among postmenopausal women. The vascular aging (EVA) study. Atherosclerosis 166 (2003) 163-170
28. Liang Y.L., Teede H., Shiel L.M., et al. Effects of oestrogen and progesterone on age-related changes in arteries of postmenopausal women. Clin. Exp. Pharmacol. Physiol. 24 (1997) 457-459
29. Manson J.E., Allison M.A., Rossouw J.E., et al. Estrogen therapy and coronary-artery calcification. N. Engl. J. Med. 356 (2007) 2591-2602
30. McLaughlin V.V., Hoff J.A., and Rich S. Relation between hormone replacement therapy in women and coronary artery disease estimated by electron beam tomography. Am. Heart J. 134 (1997) 1115-1119
31. Mendelsohn M.E., and Karas R.H. The protective effects of estrogen on the cardiovascular system. N. Engl. J. Med. 340 (1999) 1801-1811
32. Michels K.B. Hormone replacement therapy in epidemiologic studies and randomized clinical trials - are we checkmate?. Epidemiology 14 (2003) 3-5
33. Mihmanli V., Mihmanli I., Atakir K., et al. Carotid intima-media thickness in surgical menopause: women who received HRT versus who did not. Maturitas 42 (2002) 37-43
34. Mikkola T.S., and Clarkson T.B. Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc. Res. 53 (2002) 605-619
35. Moreau K.L., Donato A.J., Seals D.R., et al. Arterial intima-media thickness: site-specific associations with HRT and habitual exercise. Am. J. Physiol, Heart Circ. Physiol. 283 (2002) 1409-1417
36. Mori T., Durand J., Chen Y., Thompson J.A., Bakir S., and Oparil S. Effects of short-term estrogen treatment on the neointimal response to balloon injury of rat carotid artery. Am. J. Cardiol. 85 (2000) 1276-1279
37. Nabulsi A.A., Folsom A.R., Szklo M., White A., Higgins M., and Heiss G. No association of menopause and hormone replacement therapy with carotid artery intima-media thickness. Atherosclerosis Risk in Communities (ARIC) study investigators. Circulation 94 (1996) 1857-1863
38. Nabulsi A.A., Folsom A.R., White A., et al. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities study investigators. N. Engl. J. Med. 328 (1993) 1069-1075
39. O'Leary D.H., Polak J.F., Wolfson Jr. S.K., et al. Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS collaborative research group. Stroke 22 (1991) 1155-1163
40. Piantadosi S. Larger lessons from the Women's Health Initiative. Epidemiology 14 (2003) 6-7
41. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
42. Sator M.O., Joura E.A., Gruber D.M., et al. The effect of hormone replacement therapy on carotid arteries: measurement with a high frequency ultrasound system. Maturitas 30 (1998) 63-68
43. Schisterman E.F., Gallagher A.M., Bairey Merz C.N., et al. The association of hormone replacement therapy and coronary calcium as determined by electron beam tomography. J. Women's Health Gend.-Based Med. 11 (2002) 631-638
44. Shemesh J., Frenkel Y., Leibovitch L., Grossman E., Pines A., and Motro M. Does hormone replacement therapy inhibit coronary artery calcification?. Obstet. Gynecol. 89 (1997) 989-992
45. Stampfer M. Commentary: hormones and heart disease: do trials and observational studies address different questions?. Int. J. Epidemiol. 33 (2004) 454-455
46. Stampfer M.J., and Colditz G.A. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev. Med. 20 (1991) 47-63
47. Stevenson J.C. The metabolic basis for the effects of HRT on coronary heart disease. Endocrine 24 (2004) 239-244
48. Takahashi K., Tanaka E., Murakami M., et al. Long-term hormone replacement therapy delays the age related progression of carotid intima-media thickness in healthy postmenopausal women. Maturitas 49 (2004) 170-177
49. Tremollieres F.A., Cigagna F., Alquier C., Cauneille C., Pouilles J., and Ribot C. Effect of hormone replacement therapy on age-related increase in carotid artery intima-media thickness in postmenopausal women. Atherosclerosis 153 (2000) 81-88
50. van Baal W.M., Emeis J.J., van der Mooren M.J., Kessel H., Kenemans P., and Stehouwer C.D. Impaired procoagulant-anticoagulant balance during hormone replacement therapy? A randomised, placebo-controlled 12-week study. Thromb. Haemost. 83 (2000) 29-34
51. Westendorp I.C., in 't Veld B.A., Bots M.L., et al. Hormone replacement therapy and intima-media thickness of the common carotid artery: the Rotterdam study. Stroke 30 (1999) 2562-2567
52. Whittemore A.S., and McGuire V. Observational studies and randomized trials of hormone replacement therapy: what can we learn from them?. Epidemiology 14 (2003) 8-10
53. Zou G. A modified poisson regression approach to prospective studies with binary data. Am. J. Epidemiol. 159 (2004) 702-706